The adaptive immune response generated following tumor implantation can be followed over time to map initial populations of tumor-specific CD8 T cells that can engender anti-tumor immunity, and later development of T regulatory cells that suppress anti-tumor immune control by the CD8 T cells (73–77). This evidence concerns the gene CD8A and neoplasm.